ARCA biopharma Files $75M Shelf Registration Statement By: Benzinga via Benzinga April 04, 2014 at 16:05 PM EDT ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, ... Read More >>